| Literature DB >> 31662969 |
Miłosz Czuba1,2,3, Grzegorz Bril2, Kamila Płoszczyca1, Zofia Piotrowicz2, Małgorzata Chalimoniuk4, Robert Roczniok2, Agnieszka Zembroń-Łacny3, Dagmara Gerasimuk2, Józef Langfort2.
Abstract
The main objective of this research was to evaluate the efficacy of intermittent hypoxic training (IHT) on aiming performance and aerobic capacity in biathletes. Fourteen male biathletes were randomly divided into a hypoxia group (H) (n = 7), which trained three times per week in a normobaric hypoxic environment (FiO2 = 16.5%, 2000 m a.s.l.) with lactate threshold intensity (LT) determined in hypoxia, and a control group (C) (n = 7), which exercised under normoxic conditions with LT intensity determined in normoxia. The training program included three weekly microcycles, followed by three days of recovery. The main part of the interval workout consisted of four 7 min (1st week), 8 min (2nd week), or 9 min (3rd week) running bouts at treadmill separated by 2 minutes of active recovery. After the warm-up and during the rest between the bouts, the athletes performed aiming to the target in the standing position with a sporting rifle (20 s). The results showed that the IHT caused a significant (p < 0.05) increase in retention time in the target at rest (RT9rest) by 14.4% in hypoxia, whereas RT postincremental test (RT9post) increased by 27.4% in normoxia and 26.7% in hypoxia. No significant changes in this variable were found in group C. Additionally, the capillary oxygen saturation at the end of the maximal effort (SO2capillary max) in hypoxia increased significantly (p < 0.001) by ∼4% after IHT. The maximal workload during the incremental test (WRmax) in normoxia also increased significantly (p < 0.001) by 6.3% after IHT. Furthermore, in absolute and relative values of VO2max in normoxia, there was a propensity (p < 0.07) for increasing this value by 5% in group H. In conclusion, the main findings of this study showed a significant improvement in resting and postexercise aiming performance in normoxia and hypoxia. Furthermore, the results demonstrated beneficial effects of the IHT protocol on aerobic capacity of biathletes.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31662969 PMCID: PMC6778904 DOI: 10.1155/2019/1287506
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Characteristics of study participants.
| Variable | Group H ( | Group C ( |
|---|---|---|
| Age (years) | 21.2 ± 1.5 | 20.1 ± 2.0 |
| Training experience (years) | 7.1 ± 1.5 | 6.5 ± 1.1 |
| Body height (cm) | 179.8 ± 4.7 | 180.2 ± 3.1 |
| Body mass (kg) | 73.2 ± 4.2 | 71.1 ± 5.1 |
| Fat content (%) | 9.8 ± 4.1 | 10.4 ± 2.7 |
| VO2max (ml/kg/min) | 63.6 ± 4.8 | 65.7 ± 1.5 |
Figure 1Illustration of the study design.
Variables indicating aim-point fluctuation.
| Variable | Description |
|---|---|
| RT9 (%) | Percent of retention time in the area of 9.0 during 20 s aiming test. Greater RT9 values indicate better steadiness of aiming. |
|
| |
| LHTT (mm) | Length of the horizontal tracking trace. |
| Smaller LHTT values indicate decrease in aim-point fluctuation in the | |
|
| |
| LVTT (mm) | Length of the vertical tracking trace. |
| Smaller LVTT values indicate decrease in aim-point fluctuation in the | |
|
| |
| MTTS (mm/s) | Maximum target tracking speed. |
| Smaller MTTS values indicate decrease in aim-point fluctuation. | |
Figure 2Training loads during investigation in the hypoxia (H) and control (C) groups.
Mean values selected shooting indicators recorded in the experimental and control groups (H, n = 7; C, n = 7) at rest and postincremental test in normoxia.
| Variable | Group H | Cohen's | Group C | Cohen's | ANOVA | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S1N | S2N | S3N |
|
|
| S1N | S2N | S3N |
|
|
| Time | Group | Interaction | |
| RT9rest (%) | 63.28 ± 8.51 | 66.42 ± 11.50 | 63.00 ± 9.72 | 0.34 | 0.35 | 0.03 | 61.00 ± 6.61 | 60.85 ± 7.69 | 59.00 ± 6.20 | 0.02 | 0.29 | 0.35 |
|
|
|
|
| |||||||||||||||
| RT9post (%) | 41.28 ± 9.77 |
| 43.28 ± 10.59 | 1.23 | 0.96 | 0.29 | 38.42 ± 6.34 | 37.85 ± 2.26 | 37.00 ± 6.44 | 0.13 | 0.19 | 0.24 |
|
|
|
|
| |||||||||||||||
| LVTTrest (mm) | 62.28 ± 9.91 | 59.85 ± 10.41 | 57.71 ± 14.51 | 0.26 | 0.18 | 0.40 | 70.71 ± 16.19 | 68.14 ± 10.42 | 82.14 ± 22.70 | 0.20 | 0.85 | 0.63 |
|
|
|
|
| |||||||||||||||
| LVTTpost (mm) | 100.71 ± 10.17 |
| 98.57 ± 6.26 | 1.71 | 1.76 | 0.27 | 103.57 ± 24.61 | 107.00 ± 13.97 | 101.42 ± 114.92 | 0.47 | 0.26 | 0.21 |
|
|
|
|
| |||||||||||||||
| LHTTrest (mm) | 69.71 ± 15.98 | 64.42 ± 8.40 | 66.14 ± 10.60 | 0.45 | 0.19 | 0.28 | 77.42 ± 12.16 | 80.57 ± 13.98 | 83.00 ± 15.43 | 0.26 | 0.18 | 0.43 |
|
|
|
|
| |||||||||||||||
| LHTTpost (mm) | 96.57 ± 19.93 | 92.28 ± 13.16 | 96.42 ± 14.35 | 0.27 | 0.32 | 0.01 | 89.42 ± 11.70 | 90.28 ± 8.38 | 93.42 ± 12.08 | 0.09 | 0.33 | 0.36 |
|
|
|
|
| |||||||||||||||
| MTTSrest (mm/s) | 196.42 ± 26.88 | 179.42 ± 17.71 | 187.85 ± 29.13 | 0.81 | 0.38 | 0.33 | 186.00 ± 10.26 | 188.57 ± 16.76 | 191.28 ± 35.72 | 0.20 | 0.11 | 0.22 |
|
|
|
|
| |||||||||||||||
| MTTSpost (mm/s) | 250.71 ± 62.07 | 215.71 ± 56.78 | 247.00 ± 30.52 | 0.65 | 0.78 | 0.06 | 244.42 ± 46.94 | 241.57 ± 15.07 | 248.57 ± 25.93 | 0.09 | 0.36 | 0.12 |
|
|
|
Test series in normoxia: S1N, before training; S2N, 3 and 4 days after training; S3N, 14 and 15 days after training. Effect size: d1, between S1N and S2N; d2, between S2N and S3N; d3, between S1N and S3N. p < 0.05, statistically significant differences in relation to initial measurements (S1N). RT9, percent of retention time in the area of 9.0 during 20 s aiming test; LVTT, length of the vertical tracking trace; LHTT, length of the horizontal tracking trace; MTTS, maximum target tracking speed; rest, at rest; post, postexercise.
Mean values of selected shooting indicators recorded in the experimental and control groups (H, n = 7; C, n = 7) at rest and postincremental test in hypoxia (2000 m).
| Variable | Group H | Cohen's | Group C | Cohen's | ANOVA | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S1N | S2N | S3N |
|
|
| S1N | S2N | S3N |
|
|
| Time | Group | Interaction | |
| RT9rest (%) | 57.42 ± 9.62 |
|
| 1.04 | 0.88 | 0.36 | 54.42 ± 4.19 |
| 55.40 ± 2.63 | 0.94 | 0.82 | 0.31 |
|
|
|
|
| |||||||||||||||
| RT9post (%) | 39.57 ± 7.72 |
| 43.28 ± 8.65 | 1.13 | 0.71 | 0.49 | 38.85 ± 4.37 | 39.42 ± 4.75 | 37.85 ± 7.15 | 0.14 | 0.28 | 0.18 |
|
|
|
|
| |||||||||||||||
| LVTTrest (mm) | 64.42 ± 17.43 | 59.00 ± 8.38 | 64.28 ± 7.29 | 0.43 | 0.73 | 0.01 | 64.00 ± 7.85 | 64.57 ± 12.63 | 66.42 ± 3.99 | 0.06 | 0.21 | 0.42 |
|
|
|
|
| |||||||||||||||
| LVTTpost (mm) | 106.14 ± 6.59 |
|
| 2.07 | 0.79 | 0.21 | 114.28 ± 10.96 | 112.85 ± 7.49 | 111.14 ± 7.42 | 0.16 | 0.20 | 0.31 |
|
|
|
|
| |||||||||||||||
| LHTTrest (mm) | 75.75 ± 21.88 | 68.14 ± 11.06 | 70.71 ± 12.72 | 0.46 | 0.23 | 0.29 | 77.42 ± 15.26 | 74.85 ± 7.91 | 76.28 ± 11.11 | 0.23 | 0.16 | 0.09 |
|
|
|
|
| |||||||||||||||
| LHTTpost (mm) | 89.42 ± 16.45 | 77.74 ± 16.52 | 93.71 ± 17.93 | 0.77 | 1.00 | 0.27 | 107.42 ± 11.45 | 110.42 ± 12.47 | 117.42 ± 11.31 | 0.27 | 0.63 | 0.95 |
|
|
|
|
| |||||||||||||||
| MTTSrest (mm/s) | 193.57 ± 11.80 | 172.85 ± 15.77 | 183.85 ± 18.55 | 1.61 | 0.69 | 0.67 | 186.00 ± 10.26 | 188.57 ± 16.76 | 191.28 ± 35.72 | 0.24 | 0.52 | 0.20 |
|
|
|
|
| |||||||||||||||
| MTTSpost (mm/s) | 281.42 ± 71.51 | 253.57 ± 61.82 | 266.42 ± 39.44 | 0.45 | 0.27 | 0.28 | 291.42 ± 33.30 | 288.57 ± 37.04 | 290.71 ± 30.33 | 0.09 | 0.07 | 0.02 |
|
|
|
Test series in hypoxia: S1H, before training; S2H, 3 and 4 days after training; S3H, 14 and 15 days after training. Effect size: d1, between S1H and S2H; d2, between S2H and S3H; d3, between S1H and S3H. p < 0.05, statistically significant differences in relation to initial measurements (S1H). #p < 0.05, statistically significant differences in relation to 3 days post-IHT measurements (S2H). RT9, percent of retention time in the area of 9.0 during 20 s aiming test; LVTT, length of the vertical tracking trace; LHTT, length of the horizontal tracking trace; MTTS, maximum target tracking speed; rest, at rest; post, postexercise.
Figure 3The percent of retention time in the area of 9.0 during 20 s aiming exercise at rest (RT9rest) and after 1st, 2nd, 3rd, and 4th bout (RT9 1st, RT9 2nd, RT9 3rd, and RT9 4th) in the experimental and control groups (H, n = 7; C, n = 7) during the first and last training sessions in normoxia and hypoxia (2000 m). p < 0.01 indicates statistically significant differences in relation to initial measurements. p < 0.05 indicates statistically significant differences in relation to initial measurements.
Mean values of maximal workload and selected cardiorespiratory indices recorded in the experimental and control groups (H, n = 7; C, n = 7) during the incremental test in normoxia.
| Variable | Group H | Cohen's | Group C | Cohen's | ANOVA | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S1N | S2N | S3N |
|
|
| S1N | S2N | S3N |
|
|
| Time | Group | Interaction | |
| WRmax (W) | 372.14 ± 14.72 |
|
| 1.56 | 0.70 | 1.03 | 361.71 ± 26.06 | 369.40 ± 23.27 | 354.28 ± 32.42 | 0.34 | 0.58 | 0.27 |
|
|
|
|
| |||||||||||||||
| VO2max (l/min) | 4646.71 ± 271.83 |
| 4762.42 ± 420.04 | 0.88 | 0.36 | 0.35 | 4686.28 ± 413.80 | 4614.85 ± 372.69 | 4523.00 ± 498.84 | 0.20 | 0.23 | 0.38 |
|
|
|
|
| |||||||||||||||
| VO2max (ml/kg/min) | 63.57 ± 4.79 |
| 66.71 ± 6.75 | 0.71 | 0.05 | 0.58 | 65.71 ± 1.49 | 65.14 ± 2.19 | 63.57 ± 2.69 | 0.33 | 0.69 | 1.06 |
|
|
|
|
| |||||||||||||||
| VEmax (l/min) | 163.18 ± 16.60 | 168.50 ± 13.22 | 164.57 ± 18.32 | 0.38 | 0.27 | 0.09 | 156.72 ± 8.56 | 163.57 ± 12.59 | 153.50 ± 11.27 | 0.69 | 0.91 | 0.35 |
|
|
|
|
| |||||||||||||||
| RERmax | 1.10 ± 0.04 | 1.14 ± 0.05 | 1.10 ± 0.03 | 0.99 | 1.03 | 0.12 | 1.10 ± 0.02 | 1.16 ± 0.03 | 1.10 ± 0.05 | 2.03 | 1.27 | 0.00 |
|
|
|
|
| |||||||||||||||
| HRmax (bpm) | 193.42 ± 6.29 | 192.28 ± 7.60 | 189.00 ± 7.75 | 0.18 | 0.47 | 0.69 | 200.57 ± 4.96 | 199.00 ± 6.92 | 196.14 ± 4.52 | 0.28 | 0.53 | 1.01 |
|
|
|
Test series in normoxia: S1N, before training; S2N, 3 and 4 days after training; S3N, 14 and 15 days after training. Effect size: d1, between S1N and S2N; d2, between S2N and S3N; d3, between S1N and S3N.p < 0.05, statistically significant differences in relation to initial measurements (S1N). §p < 0.07, propensity in relation to initial measurements (S1N). WRmax, maximal workload during the incremental test; VO2max, maximal oxygen uptake; VEmax, maximal ventilation; RERmax, maximal respiratory ratio during the incremental test; HRmax, maximal heart rate.
Figure 4The oxygen saturation at rest (SO2capillary rest) and at the end of the incremental test (SO2capillary max) in the experimental and control groups (H, n = 7; C, n = 7) in normoxia and hypoxia (2000 m). p < 0.01 indicates statistically significant differences in relation to initial measurements in hypoxia. p < 0.05, indicates statistically significant differences in relation to 3 days post-IHT measurements.
Mean values of maximal workload and selected cardiorespiratory indices recorded in the experimental and control groups (H, n = 7; C, n = 7) during the incremental test in hypoxia (2000 m).
| Variable | Group H | Cohen's | Group C | Cohen's | ANOVA | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S1N | S2N | S3N |
|
|
| S1N | S2N | S3N |
|
|
| Time | Group | Interaction | |
| WRmax (W) | 347.85 ± 19.10 | 350.71 ± 16.97 | 349.42 ± 18.84 | 0.17 | 0.08 | 0.09 | 312.00 ± 26.08 | 314.14 ± 24.40 | 317.71 ± 22.35 | 0.09 | 0.16 | 0.25 |
|
|
|
|
| |||||||||||||||
| VO2max (l/min) | 4162.00 ± 328.59 | 4250.42 ± 204.20 | 4199.14 ± 241.02 | 0.35 | 0.25 | 0.14 | 3894.71 ± 428.52 | 3918.57 ± 407.45 | 4056.14 ± 450.52 | 0.06 | 0.35 | 0.40 |
|
|
|
|
| |||||||||||||||
| VO2max (ml/kg/min) | 56.83 ± 5.77 | 58.83 ± 4.58 | 57.83 ± 4.62 | 0.42 | 0.18 | 0.26 | 54.42 ± 4.07 | 55.14 ± 3.80 | 57.42 ± 2.29 | 0.20 | 0.79 | 0.98 |
|
|
|
|
| |||||||||||||||
| VEmax (l/min) | 167.17 ± 15.15 | 166.14 ± 17.99 | 171.41 ± 18.45 | 0.27 | 0.31 | 0.07 | 153.80 ± 10.46 | 155.57 ± 10.41 | 152.21 ± 9.25 | 0.18 | 0.37 | 0.17 |
|
|
|
|
| |||||||||||||||
| RERmax | 1.10 ± 0.05 |
|
| 1.23 | 0.14 | 1.31 | 1.15 ± 0.03 | 1.14 ± 0.02 | 1.12 ± 0.02 | 0.13 | 1.02 | 0.99 |
|
|
|
|
| |||||||||||||||
| HRmax (bpm) | 189.71 ± 5.96 | 187.85 ± 6.20 | 186.14 ± 7.55 | 0.33 | 0.27 | 0.57 | 193.42 ± 4.54 | 193.71 ± 4.95 | 191.42 ± 4.68 | 0.06 | 0.51 | 0.47 |
|
|
|
Test series in hypoxia: S1H, before training; S2H, 3 and 4 days after training; S3H, 14 and 15 days after training. Effect size: d1, between S1H and S2H; d2, between S2H and S3H; d3, between S1H and S3H. p < 0.05, statistically significant differences in relation to initial measurements (S1H). WRmax, maximal workload during the incremental test; VO2max, maximal oxygen uptake; VEmax, maximal ventilation; RERmax, maximal respiratory ratio during the incremental test; HRmax, maximal heart rate.
Figure 5Delta heart rate during 1-minute recovery (delta HRpost) following the incremental test in the experimental and control groups H, (n = 7; C, n = 7) in normoxia and hypoxia (2000 m).
Mean values of body mass and percent of body fat in the experimental (H, n = 7) and control groups (C, n = 7) during investigation.
| Variable | Group H | Cohen's | Group C | Cohen's | ANOVA | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S1 | S2 | S3 |
|
|
| S1 | S2 | S3 |
|
|
| Time | Group | Interaction | |
| BM (kg) | 73.2 ± 4.2 | 71.7 ± 3.2 | 72.4 ± 3.6 | 0.41 | 0.20 | 0.22 | 71.1 ± 5.1 | 70.7 ± 4.3 | 70.9 ± 5.5 | 0.09 | 0.04 | 0.04 |
|
|
|
| % fat | 9.8 ± 4.1 | 9.8 ± 3.6 | 9.6 ± 3.9 | 0.01 | 0.07 | 0.08 | 10.4 ± 2.7 | 10.5 ± 1.9 | 9.2 ± 0.84 | 0.03 | 0.83 | 0.62 |
|
|
|
S1, before training; S2, 3 days after training; S3, 14 days after training. Effect size: d1, between S1 and S2; d2, between S2 and S3; d3, between S1 and S3. BM—body mass; % fat—percent of body fat.